The significance of adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease;Značaj adiponektina kao biomarkera metaboličkog sindroma i/ili koronarne bolesti

Vojnosanitetski Pregled

Volumn 72, Issue 9, 2015, Pages 779-784

  Stojanović, Sanja ^a   Ilić, Marina Deljanin ^a   Ilić, Stevan ^a   Petrović, Dejan ^a   Djukić, Svetlana ^b  

^a Institute for Treatment and Rehabilitation Ni ka Banja   (Serbia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Adiponectin; Biological markers; Coronary disease; Metabolic syndrome x

Indexed keywords

ADIPONECTIN; LEPTIN; RESISTIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; RADIOIMMUNOASSAY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; ANALYSIS; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE COURSE; GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; SERBIA;

ADIPONECTIN; ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SERBIA;

EID: 84940488129     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP140531067S     Document Type: Article

References (28)

1. Boydens C, Maenhaut N, Pauwels B, Decaluwé K, van de Voorde J. Adipose tissue as regulator of vascular tone. Curr Hypertens Rep 2012; 14(3): 270-8.
2. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121(6): 2111-7.
3. Lago F, Gómez R, Gómez-Reino JJ, Dieguez C, Gualillo O. Adipokines as novel modulators of lipid metabolism. Trends Biochem Sci 2009; 34(10): 500-10.
4. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316(2): 129-39.
5. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45, 891 Individuals. PLoS Genet 2012; 8(3): 1002607.
6. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AE,. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001; 86(9): 4321-5.
7. Hui X, Lam KS, Vanhoutte PM, Xu A. Adiponectin and cardiovascular health: an update. Br J Pharmacol 2012; 165(3): 574-90.
8. Cheng KK, Lam KS, Wang B, Xu A. Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin. Best Pract Res Clin Endocrinol Metab 2014; 28(1): 3-13.
9. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010; 91(1): 258-61.
10. Aronne LJ, Segal KR. Adiposity and Fat Distribution Outcome Measures: Assessment and Clinical Implications. Obes Res 2002; 10(1): 14-21.
11. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: Department of Noncommunicable Disease Surveillance; 1999.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-9.
13. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, De Francisco A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 2013; 13(1): 47.
14. RND sistems. Human Adiponectin/Acrp30 DuoSet. Available from: http://www. rndsystems. com/Products/DY1065.
15. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 2012; 148(5): 852-71.
16. Saely CH, Risch L, Hoefle G, Rein P, Muendlein A, Marte T, et al. Low serum adiponectin is independently associated with both the metabolic syndrome and angio-graphically determined coronary atherosclerosis. Clin Chim Acta 2007; 383(1-2): 97-102.
17. Luo S, Lei H, Liu Q. Correlation between serum adiponectin and risk factors in patients with coronary artery disease. Clin Lab 2013; 59(1-2): 121-6.
18. Oliveira GB, França JÍ, Piegas LS. Serum adiponectin and cardiometabolic risk in patients with acute coronary syndromes. Arq Bras Cardiol 2013; 101(5): 399-409.
19. Wang Y, Lam K, Yau M, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 2008; 409(3): 623-33.
20. Kim JY, Choi EY, Mun HS, Min PK, Yoon YW, Lee BK, et. al. Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity ccording to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. Cardiovasc Diabetol 2013; 12: 140.
21. Indulekha K, Surendar J, Anjana RM, Gokulakrishnan K, Balasubramanyam M, Aravindhan V, et al. Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress and inflammation in Asian Indians. Dis Markers 2012; 33(4): 185-92.
22. Medina-Bravo P, Meza-Santibáñez R, Rosas-Fernández P, Galván-Duarte R, Saucedo-García R, Velázquez-López L, et al. Decrease in serum adiponectin levels associated with visceral fat accumulation independent of pubertal stage in children and adolescents. Arch Med Res 2011; 42(2): 115-21.
23. Hajer GR, van Haeften TW, Visseren F. Adipose tissue dysfunction in obesity, diabetes and vascular diseases. Europ Heart J 2008; 29(24): 2959-71.
24. Trayhurn P, Bing C, Wood S. Adipose Tissue and Adipokines-Energy Regulation from the Human Perspective. J Nutr 2006; 136(7): 1935-9.
25. Shams M, Rasekhi Kazerouni A, Ostovan MA, Omrani GR. The relationship between serum adiponectin levels with the presence and severity of coronary artery disease. Arch Iran Med 2012; 15(10): 611-6.
26. Golubović MV, Dimić D, Antić S, Radenković S, Djindjić B, Jovanović M. Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women-the effect of body weight reduction by caloric restriction. Vojnosanit Pregl 2013; 70(3): 284-91. (Serbian).
27. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005; 54(4): 476-81.
28. Shahid A, Sager A, Muhammad FM, Syed DH, Kiran N, Muhammad SH. Role of adiponectin as a biomarker of prediabetes. Med Channel 2012; 18(4): 72-5.